XyloCor Therapeutics logo

XyloCor Therapeutics


XyloCor Therapeutics is a development-stage, biotechnology company dedicated to developing first-in-class gene therapies for patients with unmet medical need in cardiovascular disease.


Add photos to showcase XyloCor Therapeutics’s culture


Add XyloCor Therapeutics’s values

Insider experiences

Share your experience of working at XyloCor Therapeutics

Albert Gianchetti
Chief Executive Officer
Rickey Reinhardt
Chief Medical Officer
Howard Dittrich
SVP Research & Development
Dawn Byrnes
VP, Clinical Operations
Mark Peterson
Clinical Trial Manager
Jennifer Augusti
Operations & Finance
Michael Carson
VP, Finance
Alexander Gaidamaka
SVP of Technology, Manufacturing & Quality

Add your teams to show how people work together at XyloCor Therapeutics

Add jobs to your org chart to show candidates who they’ll work with

Publish company announcements to get more exposure